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Throughout the twenty-first century, evidence has been continually increasing to show
the importance of epigenetic regulation in health. While the term “epigenetics” can be
applied to many different processes, the focus of this dissertation will be on microRNAs
and chromatin structure. Ultimately, both of these forms of epigenetic regulation can be
used to fine tune gene expression based on environmental cues. The first three chapters of
the dissertation focus on microRNA bioavailability, stability, and function from two
commonly consumed food products: cow’s milk and chicken eggs. This important work
has been the first of its kind to demonstrate the bioavailability and function of dietary,
animal-based microRNAs. In order to test our hypothesis that dietary microRNA are
indeed bioavailable, many experimental protocols have been used. Human feeding
studies are the prominent tool used, but important discoveries have been made in cell
culture and in a mouse feeding study that add to the significance of this work. The final
chapter will focus on a well-known histone modifier: sulforaphane. There have been
many positive roles attributed to this compound, but the work presented here describes
some potentially negative consequences of high sulforaphane intake. Overall, the

conclusion of this work is dietary microRNA are bioavailable and can regulate
endogenous gene expression. For the scientific field to determine the contribution of
dietary microRNAs to overall health, much more work will need to be performed but the
evidence provided in this dissertation indicates it is likely dietary microRNAs play a key
role in overall epigenetic regulation. Ongoing studies in our laboratory to further this
work and answer some of the current questions are also briefly described.
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INTRODUCTION

While one of just many layers of determining overall gene activity, epigenetic control is
an important factor for determining the phenotype at the cellular and organism level.
Literally meaning “over, outside, or around” the genome, epigenetics can refer to many
biological events that influence gene expression. One type of epigenetic regulation that is
constantly receiving more interest is non-coding RNA. Non-coding RNA can be broken
down into many subsets including, but not limited to, long non-coding RNA (lncRNA),
piwi interacting RNA (piRNA), and microRNAs (miRNAs). MiRNA, consisting of noncoding RNAs 18-23 nucleotides in length, have received special attention for the role
they play in regulating gene expression (1). In spite of not coding for a protein, miRNA
have been identified as having key roles in many cellular functions, including
developmental timing, cell proliferation and death, hematopoiesis, and nervous system
patterning (2).

Canonical miRNA function is accomplished by depressing protein expression of a target
gene through binding to that target gene’s mRNA in the 3’ untranslated region (UTR)
(3). The seed sequence, made of nucleotides 2-7 in a mature microRNA, is of particular
importance for binding to target transcripts (4). The mechanism by which this occurs can
be through impairing protein translation or by marking the target gene mRNA for
degradation (Fig. 1) (5, 6). While the seed sequence typically needs to be a complete
match to the target mRNA for any gene regulation to occur, the similarity, or lack
thereof, of the remaining miRNA sequence to its target will determine whether
translational inhibition or mRNA degradation are the predominant form of activity.

2

Figure 1. Biogenesis and function of microRNA. Mature microRNA result from
processing in the nucleus and cytoplasm and once loaded into protein complexes can
inhibit mRNA stability or protein translation. (Adapted from Filipowicz, 2008)

3

Traditionally, miRNA synthesized in one cell were viewed as specifically regulating
genes within the same cell. Over time, this view has expanded to include transfer of
miRNA from one cell type to another in the same and even distal tissues in the body,
typically through the use of extracellular vesicles (7, 8).

Furthermore, there is precedent for the transfer cross-kingdom transfer of miRNA
through the diet. This research suggested that miRNA-168a from rice is detectable in
human and animal sera, and osa-miR-168a decreases the expression of low-density
lipoprotein receptor adapter protein 1 mRNA, thereby inhibiting LDL receptor expression
in mouse liver (9). While the results from this initial study were very interesting, the
attempts by other researchers to replicate the data have been, in most cases, contradictory.
In short, the bioavailability of plant-borne microRNAs in humans is controversial (1013).

While there are many uncertainties regarding plant-borne miRNA bioavailability, there is
reason to suspect animal-borne miRNA are more likely to survive digestive conditions
and cross the intestinal barrier. Along with other nucleic acids and compounds, miRNA
are known to be protected from the surrounding environment by extracellular vesicles
(Fig. 2) (14, 15) One type of these vesicles, exosomes, have surface proteins that might
be important for efficient cellular uptake (16, 17). Plants may have similar structures, but
the identity and amino acid sequence of the surface proteins could be different, which in
turn would likely negatively affect the uptake of plant exosomes by human intestinal
cells.

4

Figure 2. Exosome secretion, stability, and uptake. Initially formed from
multivesicular bodies, exosomes are secreted into the extracellular space where the
exosomal phospholipid bilayer protects the contents from external conditions until the
exosome is taken up by a recipient cell via endocytosis and the contents are unpackaged.
(Adapted from Stoorvogel, 2012)

Histone modifications are another subset of epigenetic changes that can lead to greater or
lesser gene expression based on the placement and type of modification made to the
histone. One type of well-known modification is histone acetylation, which takes place at
lysine residues and typically is associated with greater transcriptional activation (18).
Equally important in overall gene regulation, the cell has histone deacetylase (HDAC)
proteins to remove the acetyl groups from histones when the gene activation they induce
is no longer needed.
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Epigenetic regulation by dietary compounds may explain some of the presumed health
benefits of foods not explained by traditional nutrition. One widely studied food
compound, found exclusively in cruciferous vegetables, is sulforaphane (SFN). SFN is
purported to have many positive characteristics, including the ability to activate tumor
suppressor genes and reduce inflammation (19). There are different hypotheses to explain
the cellular responses seen with the administration of SFN, but one that has been
experimentally validated is the ability of SFN to act as a histone deacetylase (HDAC)
inhibitor (19, 20). Once taken up by a cell, sulforaphane is metabolized into a number of
different compounds. While they all confer differing levels of biological activity, SFNCysteine seems to have the best HDAC inhibitory activity (20). Experimental and
computer modeling results indicate SFN-Cysteine probably functions as a competitive
inhibitor (Fig. 3).

By lowering the amount of HDAC activity in cells, there can be greater acetylation in the
promoter of genes responsive to HDACs. With regard to observed studies on SFN,
suppression of HDAC activity can lead to greater activation of tumor suppressor genes,
such as p21. Through the additional protection conferred by having greater p21
expression, SFN acts as a chemoprotective compound. Importantly, the activity of SFN in
this manner affects hundreds of genes, as at least 2% of genes are responsive to changing
activity of HDACs (21). Additionally, many of those genes are microRNA genes which
may have second degree effects on many other downstream targets.

6

Figure 3. Modeling of a sulforaphane/HDAC interaction. One of the metabolites of
sulforaphane, sulforaphane-cysteine fits into the HDAC active site, providing a
mechanism by which sulforaphane inhibits HDAC activity. (Adapted from Dashwood,
2005)

One set of genomic loci known to be responsive to hyperacetylation of histones are longterminal repeats (LTRs) (22). While these loci are typically heavily repressed, they can
become active with increased acetylation and when they are de-repressed, it leads to
higher risk of cancer and chromosomal abnormalities (23-29). LTRs can exist in a
solitary form, meaning it is simply the promoter elements of the retrotransposon at a
given genomic loci or they can exist as an in-tact LTR, meaning there are endogenous
retrovirus sequences present along with the promoter sequences. While most LTRs exist
in the solitary form, at least 60 in-tact, transcriptionally active LTRs have been identified

7

(30). By modification of global acetylation levels, retrotransposons may become active
potentially resulting in translocation from one genomic loci to another (Fig. 4).
Depending on the insertion site of the retrotransposon, the result can be benign or severe,
potentially resulting in tumor suppressor inactivation, oncogene activation, or disruption
of other essential genes (31-33).

Figure 4. Retrotransposon translocates between different genomic loci. The derepression of LTRs activates retro-transcription from its promoter, allowing its associated
retrotransposon to be transferred from the donor loci to recipient loci in the genome.
(Adapted from Lewin, 2004)

Conclusion

Epigenetic regulation of genes may occur through many different mechanisms.
Transcriptional activity can be increased or decreased by modifying histone positioning
based on environmental cues. Even more interestingly, microRNA present in the foods
we eat may directly be regulating expression of endogenous genes. The following
chapters will explore these ideas further and describe in detail the (i) the bioavailability of
milk-derived microRNA as demonstrated in cell culture studies, human feeding studies,

8

and mouse feeding experiments, (ii) the bioavailability of chicken egg-derived
microRNA and the biological activity of those exogenous microRNA, (iii) the stability of
milk microRNA throughout processing and conversion of milk into other food products,
and (iv) activation of LTRs following consumption of broccoli sprouts by human
subjects.
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1

Abstract

2

Background MicroRNAs regulate genes in animals and plants, and can be synthesized

3

endogenously. In milk, microRNAs are encapsulated in exosomes, thereby conferring

4

protection against degradation and facilitating uptake by endocytosis. The majority of

5

bovine microRNAs have nucleotide sequences complimentary to human gene transcripts,

6

suggesting that microRNAs in milk might regulate human genes.

7

Objective We tested the hypotheses that humans absorb biologically meaningful

8

microRNAs from nutritionally relevant doses of milk, milk-borne microRNAs regulate

9

human gene expression, and mammals cannot compensate for dietary microRNAs

10

depletion by endogenous microRNA synthesis.

11

Methods Healthy adults (3 male, 2 female, ages 26-49 years) consumed 0.25, 0.5, and 1.0

12

liter milk in a randomized cross-over design. Gene expression studies and milk

13

microRNA depletion studies were conducted in human cell cultures and mice,

14

respectively. For comparison, feeding studies with plant microRNAs from broccoli were

15

conducted in humans.

16

Results Postprandial concentration time curves suggest that meaningful amounts of

17

microRNA-29b (miR-29b) and microRNA-200c (miR-200c) were absorbed; plasma

18

concentrations of miR-1 did not change (negative control). The expression of RUNX2, a

19

known target of miR-29b, increased by 31% in blood mononuclear cells following milk

20

consumption compared with baseline. When milk exosomes were added to cell culture

21

media, mimicking postprandial concentrations of miR-29b and miR200c, reporter gene

22

activities significantly decreased by 44% and 17%, respectively, compared with vehicle

23

controls in HEK-293 human kidney cells. When C57BL/6J mice were fed a milk

18
24

microRNA-depleted diet for four weeks, plasma miR-29b levels were significantly

25

decreased by 61% compared with microRNA-sufficient controls, i.e., endogenous

26

synthesis did not compensate for dietary depletion. Broccoli sprout feeding studies were

27

conducted as a control and elicited no detectable increase in brassica-specific microRNA.

28

Conclusion We conclude that microRNAs in milk are bioactive food compounds that

29

regulate human genes.

30
31

Key words: bioavailability; bone health; dietary miRNA; milk; miR-29b
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Introduction

33

MicroRNAs are small non-coding RNA (about 22 nucleotides in mature microRNA) that

34

may silence genes via destabilizing complementary mRNA sequences or preventing

35

translation of mRNA (1, 2). The nucleotide sequence in the seed region in microRNA

36

(nucleotides 2-7) is of particular importance for binding to target (3); imperfect pairing of

37

sequences in the seed region in microRNA to mRNA impairs gene downregulation at the

38

protein or RNA level (4). MicroRNAs are encoded by their own genes, introns, or exons

39

of long nonprotein-coding transcripts (5). Traditionally, microRNAs are considered

40

endogenous regulators of genes, i.e., microRNAs synthesized by human cells regulate the

41

expression of genes in that host. We challenged this paradigm and tested the hypothesis

42

that humans absorb microRNAs from milk in meaningful quantities and milk-borne

43

microRNAs elicit biologically meaningful changes in human gene expression.

44

There is precedent for the bioavailability of dietary microRNAs in humans. A recent

45

report suggests that microRNA-168a from rice (Oryza sativa, osa-miR-168a) is

46

detectable in human and animal sera, and osa-miR-168a decreases the expression of low-

47

density lipoprotein receptor adapter protein 1 mRNA, thereby inhibiting LDL receptor

48

expression in mouse liver (6). Note that the serum concentration of osa-miR-168a is only

49

about 3 fmol/L in humans and that the bioavailability of plant-borne microRNAs in

50

humans is controversial (6-10).

51

This study focused on milk as source of dietary microRNAs, based on the rationale

52

that a large fraction of microRNAs in milk is contained in exosomes, conferring

53

protection against degradation (11, 12), Americans consume 195 pounds of milk annually

54

(13), and cow’s milk contains large quantities of 245 microRNA (14, 15). This study of
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55

milk-borne microRNAs was modeled primarily on miR-29b based on the rationale that

56

the nucleotide sequence of bovine miR-29b is identical to that of human miR-29b (16),

57

and miR-29b increases bone mineralization in humans through promoting a gain in

58

osteoblast differentiation (17) and a loss in osteoclast differentiation and function (18). In

59

select experiments, miR-200c was included because its concentration is eight times that

60

of miR-29b in cow’s milk (15). The nucleotide sequence of bovine miR-200c is identical

61

to that of human miR-200c (16), and miR-200c decreases cancer risk by targeting the

62

transcription factor zinc finger E-box binding homeobox 1 (ZEB16); miR-

63

200c―dependent loss of ZEB1 induces E-cadherin expression, thereby limiting

64

epithelial-to-mesenchymal transition ― a key event in metastasis (19, 20).

65

This study was guided by the following aims. First, we determined whether humans

66

absorb quantitatively meaningful amounts of microRNA from nutritionally relevant doses

67

of milk, and characterized the bioavailability of milk microRNAs using pharmacokinetics

68

protocols. Second, we assessed the effects of physiologically relevant microRNA

69

concentrations on the expression of endogenous genes in human peripheral blood

70

mononuclear cells (PBMC)6 and reporter genes in human cell cultures. Third, we

71

determined whether mammals compensate for dietary microRNA deficiency by an

72

increased synthesis of endogenous microRNAs in a mouse microRNA depletion study.

73

Fourth, we conducted a broccoli feeding study to determine whether plant-borne

74

microRNAs are bioavailable in humans.

75
76

Methods and Materials

21
77

Human feeding study. Five apparently healthy adults (3 male, 2 female) participated in a

78

milk feeding study using three doses of milk in a randomized cross-over design with a

79

washout period of at least a one week between doses. Exclusion criteria included

80

pregnancy, smoking, milk allergies, and self-reported health problems. Preliminary

81

studies suggested that plasma miRNA concentrations remain higher than baseline

82

concentrations until 9 hours after milk consumption; subjects were instructed not to

83

consume milk and dairy products for twelve hours before the milk meal and during the

84

period in which blood samples were collected. Doses of milk were normalized by total

85

body water of subjects, which is the suspected volume of distribution for microRNA.

86

Estimation of total body water was calculated as previously described (21).

87

Normalization of doses by body water resulted in doses of 0.218 ± 0.018, 0.436 ± 0.037,

88

and, 0.872 ± 0.073 L representing the equivalent of 0.25 L, 0.5 L, and 1.0 L in a 26 year-

89

old reference male (75 kg weight, 1.83 m height). Twenty milliliters of blood were

90

collected before milk consumption (baseline, time 0 h) and at timed intervals (1, 2, 3, 6,

91

9, 24 h) after the milk meal. PBMC and plasma were collected using gradient

92

centrifugation as described previously (22) and frozen at -80°C until analysis. This

93

protocol was approved by the University of Nebraska-Lincoln Institutional Review Board

94

and all participants provided signed informed consent forms prior to participation.

95
96

Quantitative real-time PCR (qRT-PCR). The sequences of mature bovine miR-29b (bta-

97

miR-29), miR-200c (bta-miR-200c), and miR-1 (bta-miR-1; control) are identical to their

98

human and murine orthologs and, therefore, qRT-PCR amplification targeted the mature

99

human miR-29b (hsa-miR-29b-3p), miR-200c (hsa-miR-200c-3p), and miR-1 (hsa-miR-

22
100

1-3p) that originate in the 3’ p arm of pre-miRNA (23). RNA was isolated from human

101

and murine (see below) plasma using the NucleoSpin miRNA Plasma kit (Machery-

102

Nagel, Bethlehem, PA). Reverse transcription was performed using the miScript II RT

103

Kit. qRT-PCR was performed using miScript SYBR Green (Qiagen, Valencia, CA) and

104

the universal reverse primer included in the kit primers specific for individual microRNA

105

(Supplemental Table 1). MicroRNA-1 is not detectable in milk (data not shown) and

106

served as negative control. Five attomoles of synthetic miRNA, miSPIKE (IDT DNA,

107

Coralville, IA), were added to each sample after denaturation of plasma with lysis buffer

108

and served as external standard and for calibration of qRT-PCR.

109
110

Pharmacokinetics analysis. Areas under the curves for plasma miRNA were calculated

111

using the linear trapezoidal rule to assess the apparent bioavailability of microRNA (24).

112

Plasma concentrations of miR-29b and miR-200c returned to baseline levels nine hours

113

after consumption of the two lowest doses of milk. For the calculation of AUC, baseline

114

values were subtracted from postprandial concentrations and the plasma concentrations

115

from the first nine hours after milk meals were used. The maximal plasma concentration

116

(Cmax) and the time of peak concentration (tmax) were obtained by visual inspection of the

117

plasma time curves measured for miR-29b and miR-200c. Cmax of an orally administered

118

compound is a marker of bioavailability and rate of absorption, whereas tmax is a marker

119

of the approximate absorption site (25).

120
121

Gene expression. Effects of milk-borne microRNAs on the expression of human genes

122

were assessed in cell cultures and PBMC from the human milk feeding studies. For

23
123

studies in cell cultures, HEK-293 human embryonic kidney cells (American Type Culture

124

Collection, Manassas, VA) were cultured in Minimum Essential Medium containing 10%

125

exosome-depleted fetal bovine serum, 0.1% sodium pyruvate, 100,000 U/L penicillin,

126

and 100 mg/L streptomycin for 10 days. Bovine serum was depleted of exosomes by

127

ultracentrifugation at 130,000 x g for 4 hours, leading to the removal of 97% and 81% of

128

miR-29b and miR-200c, respectively. Cells were transfected with microRNA reporter

129

genes as described previously (26). Forty-eight hours after transfection, exosome-

130

depleted media was replaced with exosome-sufficient media at final concentrations of

131

600 fmol/L miR-29b or 1000 fmol/L miR-200c. Exosome-sufficient media were prepared

132

using exosomes collected from cow’s milk as previously described (27). The

133

concentrations of miR-29b and miR-200c in exosomes were quantified using qRT-PCR,

134

and exosomes were added back to culture media to produce the desired concentrations of

135

microRNA. Reporter genes for miR-29b and miR-200c were created by inserting the 3’-

136

untranslated regions (3’-UTR) from genes COL1A1 (three miR-29b binding sites) and

137

ZEB1 (two miR-200c binding sites), respectively, downstream of the luciferase reading

138

frame, driven by a cytomegalovirus promoter, thereby creating plasmids LUC-mir29b

139

and LUC-mir200c (Supplemental Fig. 1). LUC-mir200c was obtained from Dr. Thomas

140

Brabletz (University of Freiburg, Germany) and is denoted ZEB1 3’UTR-Luc in the

141

original publication (20). LUC-mir29b was created by digesting LUC-mir200c with MluI

142

and HindIII to remove the ZEB1 sequence. The 3’-untranslated regions of COL1A1 was

143

amplified by PCR (Supplemental Table 1) using IMR-90 fibroblast DNA as template

144

and ligated into the reporter plasmid using MluI and HindIII. Cells were co-transfected

145

with plasmid RSV-β-galactosidase and luciferase plasmids to assess transfection

24
146

efficiency (28). Reporter gene activities were normalized by transfection efficiency. Our

147

rationale for choosing HEK-293 cells was that these cells can be transfected with near

148

100% efficiency and express COL1A1 in meaningful quantities (29, 30).

149

For studies in human PBMC, a preliminary time-response screen was conducted to

150

determine the time point when the effects of milk on the expression of Runt-related

151

transcription factor 2 (RUNX2) and , zinc finger E-box binding homeobox 1 (ZEB1)

152

mRNA were maximal. RUNX2 is a downstream target of miR-29b-dependent signaling

153

pathways; note that miR-29b is a positive regulator of the expression of RUNX2 (17). Our

154

preliminary assessment suggested that changes in mRNA abundance were maximal 6 h

155

after milk consumption (Supplemental Fig. 2, positive and negative changes for RUNX2

156

and ZEB1 mRNA, respectively). Therefore, subsequent assays of RUNX2 and ZEB1

157

mRNA were conducted using samples from time point 6 h after the milk meal, using

158

qRT-PCR (Online Table 1) and the ΔΔCt method (31); GAPDH was used to normalize

159

for amplification efficiency (32). Abundance of miRNA was measured as described for

160

plasma samples except that normalization was performed using U6 rather than miSPIKE.

161
162
163

Mouse feeding study. A microRNA depletion study was conducted in mice to determine

164

whether endogenous microRNA synthesis compensates for dietary deficiency. Ten

165

female C57BL/6J mice (Jackson Labs, stock 000664), age 3 weeks, were randomly

166

divided between a milk microRNA-depleted treatment group (denoted ExoMinus) and a

167

milk microRNA-sufficient control group (ExoPlus). Diets were based on the AIN-93G

168

formula with the following modifications and were fed for four weeks (33). In the

25
169

ExoMinus diet, exosome-depleted fat-free cow’s milk was substituted for casein and

170

cornstarch in the AIN-93G diet to provide 10% of total calories (Supplemental Table 2);

171

the remainder of casein in the AIN-93G diet was replaced with soy protein (Bob’s Red

172

Mill, Milwaukee, OR) to eliminate any milk-borne microRNAs. Milk was depleted of

173

exosomes by ultrasonication for 60 min (VWR Aquasonic 250T) and incubation at 37°C

174

for 60 min prior to lyophilization. Ten percent of calories represent a consumption of

175

approximately 0.5 liter of fat-free milk by an adult, based on 352 kcal/L milk and an

176

energy intake of 1760 kcal (34). The ExoPlus control diet was prepared using exosome-

177

containing milk powder, but was otherwise identical to the ExoMinus diet. Components

178

were blended and dried at 40°C overnight. No miR-29b was detectable in the ExoMinus

179

diet whereas the ExoPlus diet contained about 83 fmol/g miR-29b, assessed by qRT-

180

PCR. All mouse protocols used in this study were approved by the University of

181

Nebraska-Lincoln Institutional Animal Care and Use Committee. After four weeks of

182

feeding microRNA-defined diets, mice were euthanized by carbon dioxide and blood was

183

collected in EDTA collection tubes. Livers were excised, rinsed with cold saline, and

184

flash frozen in liquid nitrogen. Ten milligrams of liver were homogenized using lysis

185

buffer in the NucleoSpin miRNA Kit (Machery-Nagel, Bethlehem, PA) and mRNA was

186

purified following the manufacturer’s instructions. Reverse transcription was performed

187

with the High Capacity RNA-to-cDNA Kit (Life Technologies, Grand Island, NY) for

188

subsequent analysis of Kruppel-like factor 8 (KFL8) expression using qRT-PCR

189

(Supplemental Table 1).

190
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Broccoli-borne microRNAs in humans. The bioavailability of plant-borne microRNAs is

192

controversial (6-10). We used plasma samples archived from a previous broccoli sprout

193

feeding study in humans to determine whether broccoli-borne microRNAs are detectable

194

in prandial plasma samples (35). In this previous study, eight healthy adults were fed 34,

195

68, and 102 g of broccoli sprouts and timed samples were collected at t = 0, 2, 4, 8, and

196

24 hours. Here, we analyzed samples collected at t = 0 and 4 h from the highest dose of

197

broccoli sprouts for miR-824 and miR-167a in four randomly selected subjects. Total

198

RNA was isolated from 75 mg of broccoli sprouts using Trizol. Samples were analyzed

199

for miR-824 and miR-167a using qRT-PCR (Supplemental Table 1). As of today, there is

200

no evidence that humans synthesize miR-824 and miR-167a (36), i.e., the brassica-

201

specific miR-824 and plant-specific miR-167a are good markers of broccoli-borne

202

microRNAs in human blood.

203
204

Statistics. Homogeneity of variances was tested using Bartlett’s Test. Variances were

205

heterogeneous for microRNA in mouse plasma, i.e., murine plasma data were log

206

transformed prior to subsequent statistical analysis. AUC were calculated using

207

GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA). Pharmacokinetics data were

208

analyzed using repeated measures analysis of variance (ANOVA) and Fisher’s PLSD for

209

posthoc comparisons (37). PBMC gene expression data was analyzed using the paired t-

210

test, whereas plasma miRNA concentrations and liver gene expression in mice were

211

analyzed using the Wilcoxon-Signed Rank Test. StatView 5.0.1 was used for statistical

212

analyses (SAS Institute; Cary, NC). Differences were considered statistically significant

213

if p<0.05.
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215

Results

216
217

Bioavailability of milk-borne microRNAs in humans. Cow’s milk (1% fat) contained

218

148±42 pmol/L miR-29b and 680±151 pmol/L miR-200c. Humans absorbed considerable

219

amounts of miR-29b from cow’s milk (Fig. 1A). In contrast, the plasma concentration of

220

miR-1 did not change after the consumption of 1 liter milk (negative control). Plasma

221

miR-29b concentrations returned to baseline concentrations nine hours after the milk

222

meals for the 0.25-liter and 0.5-liter doses and 24 hours after the 1-liter dose. The AUC

223

for miR-29b exhibited a linear dose-response relationship regarding the amount of milk

224

consumed (Table 1). Likewise Cmax increased linearly with the amount of milk

225

consumed, if Cmax was corrected for baseline concentrations of miR-29b. Tmax was 3.4 to

226

4.2 hours after the milk meal. MiR-200c is another microRNA present in cow’s milk.

227

Humans also absorbed considerable amounts of miR-200c from cow’s milk (Fig. 1B).

228

While the postprandial AUC for miR-200c was significantly higher for the 0.5 L and 1.0

229

L doses of milk compared to the 0.25 L dose, the AUC did not exhibit a linear dose-

230

response relationship; the AUC were not significantly different between the 0.5 L dose

231

and the 1.0 L dose (Table 1).

232
233

Effects of milk microRNAs on the concentrations of microRNAs in human PBMC. Milk

234

feeding elicited an increase in the concentrations of microRNA in human PBMC that was

235

statistically significant only for miR-200c while trending towards significance for miR-

236

29b (P = 0.09) (Fig. 2).
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238

Effects of milk microRNAs on human gene expression. MicroRNA-containing milk

239

exosomes affected the activity of reporter gene plasmids. When HEK-293 cells were

240

cultured in media supplemented with milk exosomes providing 600 fmol/L miR-29b for 4

241

h, the activity of the miR-29b―dependent reporter gene LUC-mir29b decreased by

242

44±13% (P = 0.04) compared with cells cultured in exosome-depleted culture media

243

(Fig. 3A). Likewise, when HEK-293 cells were cultured in media supplemented with

244

milk exosomes providing 1000 fmol/L miR-200c for 4 h, the activity of the miR-

245

200c―dependent reporter gene LUC-mir200c decreased by 17±3% (P = 0.02) compared

246

with cells cultured in exosome-depleted culture media.

247

Milk feeding caused changes of microRNA target gene expression in human

248

PBMC. The expression of RUNX2 was 31±13% higher 6 h after the milk meal compared

249

with time 0 h (Fig. 3B, P = 0.04), consistent with the role of miR-29b as positive

250

regulator of RUNX2 (17). The difference in the expression of ZEB1 was not significantly

251

lower 6 h after the milk meal compared with time 0 h (Fig. 3B).

252
253

MicroRNA depletion studies in mice. Endogenous microRNA transcription does not

254

compensate for dietary deficiency in C57BL/6 mice. When mice were fed miRNA-

255

defined diet for four weeks, the miR-29b plasma concentration decreased by 61% from

256

152 ± 79 fmol/L in the microRNA-sufficient ExoPlus group to 60 ± 27 fmol/L in the

257

microRNA-depleted ExoMinus group (P = 0.04). The expression of KLF8 mRNA was

258

64±32% lower in microRNA-depleted mice compared with microRNA-sufficient mice (P

259

= 0.04).
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Bioavailability of broccoli microRNAs in humans. Broccoli sprouts contained 53±16

262

pmol/kg of miR-167a and 42±10 pmol/kg miR-824. No change was observed in miR-

263

167a plasma concentration in healthy adults following a broccoli sprout meal (13±4

264

fmol/L at t=0 h vs. 15±7 fmol/L at t=4 h; P = 0.85; n=4). The concentration of miR-824

265

was below detection limit (<1 fmol/L) at baseline or 4 h after broccoli sprout feeding in

266

all of the four subjects randomly chosen from our archived plasma samples (35).

267
268

Discussion

269

Some non-coding RNA, including microRNAs, play essential roles in gene regulation in

270

plant and animal kingdoms. To the best of our knowledge, this is the first study to report

271

that humans absorb quantitatively meaningful amounts of microRNA from nutritionally

272

relevant amounts of cow’s milk. Our study provides unambiguous evidence that the

273

amounts of microRNAs absorbed from milk are sufficient to alter human gene

274

expression, i.e., microRNAs from one mammalian species can affect gene networks in

275

another species. Our observation that endogenous microRNA synthesis cannot

276

compensate for dietary deficiency is of particular interest, because it implies that a

277

regular dietary microRNA intake may be important to prevent aberrant gene regulation.

278

Our observations are important from the perspective of maintaining human health,

279

based on the following rationale. First, 245 microRNAs have been identified in cow’s

280

milk (14). A preliminary analysis by sequence alignment suggests that the majority of the

281

nucleotide sequences in bovine milk match the sequences of their human orthologs. We

282

are in the process of developing algorithms for predicting human gene targets for bovine

30
283

microRNAs, and initial assessments suggest that the number of target genes will exceed

284

11,000. Second, there is unambiguous evidence linking microRNAs with human health.

285

For example, miR-29b promotes bone health through altering osteoblast and osteoclast

286

differentiation (17, 18), miR-200c decreases cancer risk by targeting the transcription

287

factor ZEB1 (19, 20), and miR-15b, miR-21, miR-27b, miR-34a, miR-106b, miR-130a,

288

miR-155, miR-200c and miR-223 have been implicated in immune function and Crohn’s

289

disease (15, 38). Third, supplementation and depletion of milk altered microRNA

290

concentrations and gene expression in human PBMC and mouse liver. For example, the

291

concentration of miR-200c was greater six hours after a milk meal compared with time

292

zero in human PBMC. Likewise, the expression of KLF8 mRNA was greater in livers

293

from milk microRNA-sufficient mice compared with milk microRNA-depleted mice.

294

Fourth, milk is an important staple in many Western diets. For example, Americans

295

consume large quantities of milk, despite a steady decline from about 237 pounds in 1987

296

to 195 pounds in 2012 (13, 39). Note that a large fraction of microRNAs in milk is

297

contained in exosomes, providing protection against degradation (11, 12). Fifth, mice can

298

be depleted of microRNAs by feeding a microRNA-depleted diet.

299

A recent report suggests that miR-168a from rice is detectable in human and

300

animal sera, and osa-miR-168a decreases the expression of LDL receptor adapter protein

301

1 in mouse liver (6). The bioavailability of plant-borne microRNAs in humans is

302

controversial (6-10). Note that this research focuses on milk-borne microRNAs for which

303

postprandial plasma levels are 200-300 times higher than those reported for osa-miR-

304

168a in humans (6), depending on the species of milk microRNA. We are skeptical of the

305

bioavailability and biological activity of plant-borne microRNAs and conducted a

31
306

preliminary screen of microRNAs following a meal providing large amounts of broccoli

307

sprouts. In our broccoli sprouts feeding study, we did not observe a postprandial increase

308

in the Brassica-specific miR-824 or miR-167a. We speculate that the absence of effect in

309

broccoli feeding studies might be due to one or some of the following factors. First,

310

exosomes carry numerous surface proteins that might be important for cellular uptake

311

(40, 41). The identity and amino acid sequence of surface proteins implicated in the

312

cellular uptake of exosomes differs between plants and mammals, which might adversely

313

affect the uptake of plant exosomes by human intestinal cells. Second, it is possible that

314

the methylation of the 3’-terminal ribose in plant microRNAs by the methyl transferase

315

HEN1 (42) impairs the intestinal transport of microRNAs. Third, the concentrations of

316

microRNAs in broccoli sprouts are moderately below the concentrations present in milk.

317

It is also unclear whether plant-based microRNAs are encapsulated in vesicles that

318

provide protection against enzymatic and non-enzymatic degradation during food

319

processing. Fourth, it is possible that the number of human genes with sequences

320

complimentary to plant microRNAs might be less than those in mammalian microRNAs.

321

We acknowledge that our broccoli feeding study is associated with some uncertainties,

322

e.g., random selection of two microRNAs and one postprandial time point.

323

Notwithstanding these uncertainties, the analysis of samples from the broccoli feeding

324

study provides a valuable negative control for our studies in milk.

325

There are some uncertainties associated with our studies of milk microRNAs.

326

First, this study assessed the apparent bioavailability of microRNAs in milk, without

327

taking into account metabolism and degradation in intestinal cells and liver. Ongoing

328

studies of microRNA transport mechanisms suggest that a substantial fraction of some

32
329

microRNA is degraded in intestinal cells. Therefore, our bioavailability data probably

330

underestimate the true extent of microRNA absorption in humans, as only a fraction of

331

the absorbed microRNAs will appear in the peripheral circulation. Second our

332

pharmacokinetics analysis suggests that postprandial plasma microRNA concentrations

333

peak about three to four hours after milk consumption. The tmax values for microRNAs

334

are slightly later than tmax observed for the vitamin riboflavin (tmax ~ 2 h) (24), which is

335

absorbed in the duodenum (43). Considering that milk meals delay gastric emptying (44),

336

we speculate that milk-borne-microRNAs are absorbed primarily in the upper intestine.

337

Third, this study focused on miR-29b, miR-200c, and miR-1 (negative control) and did

338

not formally study other microRNAs in milk. We speculate that milk exosomes enter

339

human intestinal by a mechanism that is shared by all exosomal microRNAs, and that any

340

discrimination among microRNAs would only occur after intestinal uptake.

341

Ongoing and planned activities in our laboratory include the characterization of

342

intestinal microRNA transport mechanisms, including metabolism and basolateral

343

secretion, and the characterization of milk microRNA-dependent gene networks in

344

humans using computational biology approaches.
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TABLE 1

Pharmacokinetics analysis of plasma time curves of microRNAs after milk meals in healthy adults.

Variable

miR-29b

miR-200c

miR-1

Dose

Dose

Dose

0.25 L

0.5 L

1.0 L

0.25 L

0.5 L

1.0L

1.0 L

Baseline (fmol/L)1

224 ± 43

274 ± 37

232 ± 51

375 ± 81

468 ± 103

458 ± 37

80 ± 21

Cmax (fmol/L)

372 ± 40a

484 ± 82ab

624 ± 83b

632 ± 104a

819 ± 123ab

924 ± 121b

91 ± 18

tmax (h)

4.2 ± 1.5

3.4 ± 0.7

3.6 ± 0.6

2.6 ± 0.9

3.8 ± 1.0

3.6 ± 0.6

327 ± 249a

672 ± 231a

1900 ± 275b

646 ± 187a

1800 ± 566b

2260 ± 555b

AUC (fmol/L*h)2

Values are means ± SEMs, n=5
1

Plasma concentration at time 0 hours.

2

For hours 0 through 9.

a,b

Within a variablefor the same miRNA, means without a common letter differ (P < 0.05, n =5).
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Plasma miR-29b (fmol/L)

600

A

400

miR-29b, 0.5 L milk
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200

miR-29b, 0.25 L milk
miR-1, 1 L milk

100
0

0

1000

Plasma miR-200c (fmol/L)
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B
1 L milk
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0
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12 16
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24

FIGURE 1 Plasma time curves of miR-29b (panel A), miR-1 (negative control, panel A),
and miR-200c (panel B) following a milk meal in healthy adults. Values are reported as
means, n =5. Standard deviations have been omitted for clarity (compare Table 1).
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MicroRNA abundance
(arbitrary units)

4.0

miR-29b

miR-200c

3.5
3.0
2.5

*

2.0
1.5
1.0

0.5
0

0

0

6

6

Hours

FIGURE 2 Effects of milk microRNAs on the abundance of miRNA in human
peripheral blood mononuclear cells. Values are mean ± SEM, n = 5. * Statistically
different samples indicated by asterisk, P < 0.05.

1.4

LUC-miR200c

1.2
1.0

*

0.8
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1.5
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miR-200c

0.2
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0.4
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miR-29b

*
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Relative Expression

A LUC-miR29b
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Relative Luciferase Expression
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B

*

1.0
0.5
0

Runx2

ZEB1

FIGURE 3 Effects of milk microRNAs on gene expression in humans. (A) Activities of
microRNA reporter genes in HEK-293 cells. (B) Expression of endogenous RUNX2 and
ZEB1 genes in PBMC from healthy adults. Data are mean ± SEM, n = 4 (LUC-miR29b),
n = 6 (LUC-miR200c), n = 5 (PBMC). *Different from vehicle, P < 0.05. RUNX2, Runtrelated transcription factor 2; ZEB1, zinc finger E-box binding homeobox 1.
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SUPPLEMENTAL TABLE 1 Primers used for the quantification of microRNAs in
human and murine plasma, mRNA abundance in human
PBMC and murine livers, and creating the human
COL1A1 reporter plasmid.
Amplicon
miSPIKE
U6
miR-29b
miR-200c
miR-1
miR-167a
miR-824
GAPDH
ZEB11
RUNX2
KLF8
(ZNF74)
COL1A1
3’-UTR
1

Forward Primer (5’-3’)
CTCAGGATGGCGGAGCGGTCT
CGCAAGGATGACACGCAAATT
GTAGCACCATTTGAATCAGTGTT
TAATACTGCCGGGTAATGATGGA
TGGAATGTAAAGAAGTATGTAT
TGAAGCTGCCAGCATGATCTA
TAGACCATTTGTGAGAAGGGA
TCCACTGGCGTCTTCACC
TTCAAACCCATAGTGGTTGCT
CGCCCCTCCCTGAACTCT

Reverse Primer (5’-3’)

GGCAGAGATGATGACCCTTT
TGGGAGATACCAAACCAACTG
TGCCTGCCTGGGATCTGTA

CAAGCCATTATGGTGCCTAC

ATAGAGCCCGGAGTGAGAAC

CGTGCGCATTCGGAGGAGAGTC

CGAAGCTTGAGGCCTGAGAAGCC

Abbreviations used: COL1A1, collagen, type I, alpha 1; KLF8, Kruppel-like factor 8;
RUNX2, runt-related transcription factor 2; ZEB1, zinc finger E-box binding homeobox 1.
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SUPPLEMENTAL FIGURE 1 Schematic of microRNA reporter plasmids and the βgaalctosidase control plasmid. Numerals denote the position of nucleotides in the 3’-UTR
in collagen, type I, alpha 1(COL1A1, GenBank NM_000088) and zinc finger E-box
binding homeobox 1( ZEB1, GenBank NM_001128128).
661
Puromycin

CMV Luciferase COL1A1-3’-UTRLUC-mir29b
321

Puromycin
RSV

1155

CMV

Luciferase

514

ZEB1-3’-UTR LUC-mir200c

β-galactosidase RSV-β-galactosidase
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SUPPLEMENTAL FIGURE 2 Time courses of runt-related transcription factor 2
(RUNX2) and zinc finger E-box binding homeobox 1 (ZEB1) mRNA in peripheral blood
mononuclear cells from an adult male.
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SUPPLEMENTAL TABLE 2
ExoMinus
Cornstarch
Soy Protein
Dextrinized cornstarch
Milk Powder (without
exosomes)
containing ~5% lactose
Sucrose
Soybean oil (no additives)
Fiber
Mineral mix (AIN-93G-MX)1
Vitamin mix (AIN-93G-VX)
L-Cystine
Choline bitartrate (41.1%
choline)
Tert-butylhydroquinone

1

Composition of microRNA-depleted (ExoMinus) and
microRNA-sufficient (ExoPlus) diets.
ExoPlus
Cornstarch
Soy Protein
Dextrinized cornstarch
Milk Powder (with exosomes)
containing ~5% lactose

g/kg
330
163
132
105

Sucrose
Soybean oil (no additives)
Fiber
Mineral mix (AIN-93G-MX)
Vitamin mix (AIN-93-VX)
L-Cystine
Choline bitartrate (41.1% choline)

100
70
50
35
10
3
2.5

Tert-butylhydroquinone

0.014

Abbreviation used: AIN-93G, American Institute of Nutrition growth diet; MX, mineral
mixture; VX, vitamin mixture.
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Abstract
Previous research has demonstrated the bioavailability of milk-borne microRNAs
following milk consumption by healthy adults. An important question left unanswered at
the conclusion of that study was if this phenomenon is unique to milk or if other foods
could also be a source of exogenous microRNA. To explore this possibility, we tested the
hypothesis that chicken egg microRNAs are bioavailable following consumption of hard
boiled eggs by healthy adult humans. Plasma concentrations of miR-181b peaked 9 hours
after egg consumption to 150% above baseline levels. The abundance of miR-181a was
also increased in erythrocytes 9 hours after egg consumption to levels 154% higher than
baseline values. Expression of BCL2 and BCL2A1, experimentally validated targets of
miR-181a/b, was 56% and 19% lower, respectively, in human lymphocytes nine hours
after egg consumption. We conclude that chicken egg microRNAs are bioavailable and
have the potential to influence endogenous gene expression in humans following
consumption of physiologically relevant doses of eggs.
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Introduction
MicroRNAs (MiRNAs) are a class of small non-coding RNAs about 22 nucleotides long
that play important roles in gene expression through base-pairing with complementary
sites at the 3’ untranslated region in target mRNA molecules (1). This binding inhibits
translation or can cause degradation of target mRNA. The target seed sequence which is
made of nucleotides 2-7 in microRNA is of particular importance for binding to target
transcripts (2). Most miRNA are transcribed in the nucleus like protein coding genes and
are processed in both the nucleus and cytoplasm into the active, mature form.
Traditionally, the miRNA made within one cell are thought to regulate genes in the same
cell or perhaps other cells and tissues within the same organism if transported via
extracellular vesicles (3). This paradigm was recently refuted by a recent publication
from our lab that has provided strong evidence that humans absorb milk miRNAs that in
turn have an effect on gene expression (4). Based on these novel and impactful findings,
we wanted to explore the possibility that other foods could provide exogenous miRNA
through the diet. To explore that aim, this study analyzed chicken (gallus gallus) eggs as
a potential dietary source of microRNAs. Eggs are commonly consumed in the United
States and a good source of nutrients including folate, iron, phosphorous, selenium, zinc
and vitamins B, E, A and K (5). This study analyzed the expression of chicken specific
microRNAs as well as those shared between humans and chicken (6, 7). We analyzed
miRNA-181a and miR-181b due to their high number of sequence reads in the embryonic
small RNA library as well as their role in human health. (7) The sequence of miRNA181b is homologous between chickens and humans and has been shown to reduce NF-κB
nuclear translocation resulting in an inhibition of inflammatory gene expression, NF-κB

51

activation and atherosclerosis in mice by targeting importin-α3, a protein used for NF-κB
translocation to the nucleus. (8) By inhibiting NF-κB translocation, expression of
inflammatory genes is reduced (9-11). In addition to indirect targeting through regulation
NF-κB signaling, miR-181a/b also directly target the 3’ UTR of BCL2 mRNA. (12, 13).

Materials and Methods
Human Feeding Study. Eggs were obtained from a local grocery store and hard boiled the
night before consumption. Seven healthy adults consumed three different egg doses in a
randomized crossover design with a minimum of a one week wash out period between
doses. Subjects were instructed not to consume eggs 24 hours before the egg meal as well
as during the period of blood sample collection. Twenty milliliters of blood was collected
in EDTA tubes before egg consumption (Hour 0) and at intervals 3, 4.5, 9, 12, and 24 hr
after egg consumption. Plasma, PBMC and RBC were collected using gradient
centrifugation as described previously (14) and frozen at -80°C until analysis. Urine was
collected throughout the 24 hour length of the study. This protocol was approved by the
University of Nebraska-Lincoln Institutional Review Board and all participants provided
signed informed consent forms prior to participation.

RNA Isolation and Reverse Transcription. Total RNA was isolated from 300 uL plasma
using the NucleoSpin miRNA Plasma kit with a final elution volume of 30 uL (MacheryNagel Inc., Bethlehem, PA). For PBMC and RBCs, the Zymo Quick RNA mini-prep kit
was used with a final elution volume of 30uL (Zymo Research, Irvine, CA). For all
microRNA studies, 4 uL of RNA was utilized in the miScript RT II Kit (Qiagen,
Valencia, CA). For reverse transcription of RNA in PBMC samples, 100 ng was used
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with the miScript RT II Kit using the HiFlex Buffer. Plasma samples were spiked with a
synthetic internal standard (twenty-five attomoles) prior to extraction of RNA using
miSPIKE Synthetic RNA (IDT Technologies).

Gene Expression. MicroRNAs were quantified using quantitative real-time PCR as
described previously. (15) PBMCs were assessed to analyze the effects of egg borne
miRNA on human gene expression. B-cell lymphoma 2 (BCL2) and BCL2 related
protein A1 (BCL2A1) were analyzed using samples from 0 h and 9 h post egg
consumption. Expression of mRNA was normalized to GAPDH expression and
calculated using the ΔΔCt method. (16)

Pharmacokinetics analysis. The linear trapezoidal rule was used to analyze areas under
the curve for plasma microRNA to determine the apparent bioavailability of microRNA.
(17)

Statistics. For all data sets, homogeneity of variances was tested by using the Bartlett’s
Test. GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA) was used for calculation
of AUC. Pharmacokinetics data were analyzed using repeated measures analysis of
variance (ANOVA) and posthoc comparisons were tested with Fisher’s PLSD (18).
PBMC gene expression data was analyzed using the paired t-test, whereas plasma and
RBC miRNA were analyzed using the Wilcoxon-Signed Rank Test. StatView 5.0.1 was
used for statistical analyses (SAS Institute; Cary, NC). Differences were considered
statistically significant if p<0.05.

53

Results
Bioavailability of egg-borne microRNA. A significant amount of microRNA was
absorbed by humans following egg meals (Table 1, Fig. 1). Increases in the plasma miR181b concentration were dose-dependent as the consumption of four eggs provided the
greatest response in Cmax and AUC, followed by the three egg and two egg doses (Table
1). Plasma concentration of miR-181b peaked 9 h following consumption of the 4 egg
meal with plasma concentrations returning to baseline values by 24 h after egg
consumption. The three and two egg doses saw progressively earlier tmax values and
return to baseline plasma miR-181b concentrations.

Effects of egg microRNA on PBMC and RBC microRNA concentration. Feeding of four
eggs did not result in changes to human PBMC miRNA concentrations (data not shown).
In RBCs, miR-181a was 154±41 % higher 9 h following consumption of four eggs (Fig.
2, P = 0.05) while miR-181b concentrations were not significantly higher.

Target gene expression in response to egg microRNA. Analysis of PBMC at hour 9 post
egg consumption showed BCL2 and BCL2A1 mRNA to be downregulated. The
expression of BCL2 was 56±18% lower (Fig. 3, P = 0.05) 9 h following the four egg
meal compared to baseline and the expression of BCL2A1 was19±3 % lower (Fig. 3, P =
0.02)

Discussion
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Few foods are as nutrient dense as eggs. Eggs are abundant in fat soluble vitamins,
caratenoids, known for their role in disease prevention and are one of the few dietary
contributors of vitamin K and vitamin D . Eggs are also rich in choline, a nutrient
important in brain development and memory (5). When compared to egg consumers, nonconsumers were more likely to not meet the RDA for Vitamins A, E and B12 (19).
Additionally, eggs are considered to be a functional food; meaning they provide added
physiological benefit beyond that of meeting nutritional needs (5). In spite of these
positive benefits of consuming eggs, they have received a bad reputation among the
general public due to concerns of a positive correlation between egg consumption and
cholesterol (5). Contrary to popular belief, frequent egg consumption has been found to
be inversely correlated with cholesterol levels (19, 20). While this observation has been
made by different researchers, there is yet to be a widely accepted mechanism by which
egg consumption may protect against increased cholesterol levels.
In a recent study we determined humans absorb meaningful quantities of bovine
microRNAs, which have an effect on gene expression potentially having human health
implications. (4) In the present study we observed similar effects regarding egg miRNAs
following consumption of hard boiled eggs by healthy adults. This paper shows the
importance of eggs as well as other animal food products on potential implications in
human health. Many egg borne microRNA are homologous with their human
counterparts resulting in predictable gene regulation. Among the most abundant miRNAs
in eggs, miR-181a and miR-181b have well defined physiological roles. These miRNA
have been shown to inhibit inflammation and atherosclerosis and expression of miRNA181b plasma levels are reduced in individuals with atherosclerosis (21). Additionally,
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atherosclerotic burden was found to be inversely correlated with consumption of one or
more eggs per week (22). Protection from atherosclerosis may be provided, at least in
part, by the additional miR-181b provided by egg consumption. Furthermore, egg
consumption was not associated with risk of coronary heart disease or stroke (20).
Additionally, patients presenting with sepsis have deceased levels of miR-181b compared
to control patients (8).
BCL2 and BCL2A1, known targets of NF-κB, are regulators of cell death exhibiting both
pro-apoptotic and anti-apoptotic functions. (9, 23) BCL2A1 has commonly been shown
to be overexpressed in many cancer cells including leukemia and lymphoma, exhibiting
anti-apoptotic properties by sequestering pro-apoptotic BCL2 family member proteins
(10, 24, 25). MiR-181b levels have also been shown to be inversely correlated with
progressive lymphocytic leukemia and overexpression of BCL2 in contrast to patients
presenting a stable form of the disease where miR-181b levels remained constant (26).
In summary, this research clearly demonstrates the bioavailability of chicken egg
miRNAs after consumption of hard boiled eggs by healthy adults. Importantly, the
exogenous miRNA also affect endogenous gene expression in PBMC and presumably
other body tissues. Epidemiological evidence regarding egg consumption supports the
known role of miR-181a/b with regard to protection from many vascular problems
including atherosclerosis, inflammation, and sepsis. While we are still in the early stages
of establishing the importance of dietary miRNAs, this research demonstrates that milk is
not the only food able to supply exogenous miRNA. While our group and others have
doubts about the bioavailability of plant miRNAs, results from this study support the
hypothesis that animal-based food products are dietary sources of miRNA.

56

TABLE 1

Pharmacokinetics analysis of plasma time curves of microRNAs after egg
meals in healthy adults.

miR-181b
Dose
Variable

2 eggs

3 eggs

4 eggs

Baseline (fmol/L)1

27 ± 15

22 ± 15

27 ± 17

Cmax (fmol/L)

47 ± 27a

67 ± 59ab

77 ± 60b

tmax (h)

4.5 ± 1.2

7.5 ± 2.9

8.4 ± 2.2

AUC (fmol/L*h)2

62 ± 51a

133 ± 109a

266 ± 279b

Values are means ± SD, n=7
1

Plasma concentration at time 0 hours.

2

For hours 0 through 24.

a,b

Within a variable for the same miRNA, means without a common letter differ (P <

0.05, n =7).
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FIGURE 1 Plasma time curves of miR-181b following an egg meal in healthy adults.
Different doses are represented by colored lines: black (2 eggs), red (3 eggs), and blue (4
eggs). Values are reported as means, n =7. Standard deviations have been omitted for
clarity (compare Table 1).
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FIGURE 2 Effects of egg microRNAs on the abundance of miRNA in human
erythrocytes. Black bars represent baseline (Hour 0) values and blue bars represent
miRNA abundance following egg consumption (Hour 9). Values are mean ± SD, n = 7.
Labeled means without a common letter differ, P < 0.05.
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FIGURE 3 Effects of egg microRNAs on BCL2 and BCL2A1 gene expression in PBMC
from healthy adults. Data are mean ± SD, n = 7 (Hour 0, black bars; Hour 9, blue bars).
Labeled means without a common letter differ, P < 0.05. BCL2, (B-cell lymphoma 2;
BCL2A1, BCL2-related protein A1.
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Running head: Loss of miRNAs during processing and storage of milk
1

ABSTRACT

2

MicroRNAs (miRs, miRNAs) play central roles in gene regulation. Previously, we

3

reported that miRNAs from pasteurized, store-bought bovine milk have biological

4

activity in humans. Here we assessed the effects of milk processing, storage, somatic cell

5

content, and handling by consumers on the degradation of miRNAs in milk; we also

6

quantified miRNAs in dairy products. Pasteurization and homogenization caused a 63%

7

loss of miR-200c, whereas a 67% loss observed for miR-29b was statistically significant

8

only in skim milk. Effects of cold storage and somatic cell content were quantitatively

9

minor (<2% loss). Heating in the microwave caused a 40% loss of miR-29b but no loss of

10

miR-200c. Milk fat content had no effect on miRNA stability during storage and

11

microwave heating. The concentrations of miRNAs in dairy products were considerably

12

lower than in store-bought milk. We conclude that processing of milk by dairies and

13

handling by consumers causes a significant loss of miRNAs.

14
15
16

Key words: heating, MiRNAs, milk, processing, storage
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INTRODUCTION

18

MicroRNAs (miRs, miRNAs) are small non-coding RNAs that play essential roles in the

19

regulation of genes at the posttranscriptional level in plants and animals.1 Mature

20

miRNAs are about 22 nucleotides long and bind to complementary sequences in the 3’-

21

untranslated region of mRNAs. Perfect or near perfect base pairing of the miRNAs and

22

its target mRNAs typically results in mRNAs degradation, whereas less perfect base

23

pairing typically results in inhibition of mRNAs translation.2-3 Traditionally, miRNAs

24

have been considered endogenous regulators of genes, i.e., miRNAs synthesized by a

25

given host regulate the expression of genes in that host. Recently, our laboratory refuted

26

this paradigm. We provided strong evidence that 1) humans absorb biologically

27

meaningful amounts of miRNAs from nutritionally relevant doses of cow’s milk, 2)

28

physiological concentrations of milk miRNAs affect human gene expression in vivo and

29

in cell cultures, and 3) endogenous synthesis of miRNAs does not compensate for dietary

30

miRNA deficiency in mice.4 Our discoveries were largely modeled on miR-29b and miR-

31

200c, but likely hold true for all miRNAs encapsulated in milk exosomes.5-6 To the best

32

of our knowledge, our previous paper is the first to provide unambiguous evidence that

33

miRNAs can be transferred between distinct species through dietary means. In contrast,

34

previous claims that miRNAs from plants affect human gene expression7-8 are highly

35

controversial and were met with skepticism by the scientific community.4, 9-12 Based on

36

the above observations, milk miRNAs are a novel class of bioactive food compounds as

37

defined by the National Cancer Institute in the United States.13 The discovery that milk

38

miRNAs are bioactive food compounds has broader implications as miRNAs play

39

essential roles in gene regulation,2-3 cell communication,14-15 and human health.16-23
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This study focused on determining the effect of milk processing, storage, somatic

41

cell content, and handling by consumers on two miRNAs, miR-29b and miR-200c levels

42

based on the following rationale. Our rationale for including the somatic cell count in our

43

analysis was to assess whether an increase in milk cells, as seen in mastitis, might be a

44

confounder in the analysis of milk miRNAs. In bovine milk, miR-29b and miR-200c are

45

among the most abundant miRNAs.20 MiR-29b is an important regulator of bone

46

mineralization in humans, as it increases osteoblast differentiation16 and decreases

47

osteoclast differentiation and function.17 MiR-200c decreases cancer risk by targeting the

48

transcription factor ZEB1, which induces E-cadherin expression, thereby limiting

49

epithelial-to-mesenchymal transition, a key event in metastasis.24-25 Also, the nucleotide

50

sequences of miR-29b and miR-200c in bovine milk are identical to those of their human

51

orthologs.26

52

In Western societies, the majority of milk is processed prior to consumption. In fact,

53

the production and sale of raw milk dairy products is illegal in many states in the United

54

States and pasteurization is required.27 Moreover, while the per capita consumption of

55

milk has declined from 236 pounds in 1982 to 195 pounds in 2012, total dairy

56

consumption increased by 11% during the same time period.28 Therefore, we considered

57

it worthwhile to assess the effects of processing on the miRNA content in both milk and

58

dairy products.

59

Little is known about the effects of processing and storage on milk miRNAs levels.

60

In two studies, synthetic miRNAs were added to bovine milk and their stability after

61

exposure to harsh treatments such as acid and RNase was assessed and compared to the

62

stability of endogenous miRNAs in milk.6, 20 Synthetic miRNAs were rapidly degraded,
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whereas endogenous miRNAs were resistant to treatment. However, the harsh treatments

64

applied in these studies are not representative of the treatments applied in commercial

65

dairy production. In this study, we assessed the effects of pasteurization, fat content, cold

66

storage, heating as well as processing into dairy products on content of milk miRNAs.

67
68

MATERIALS AND METHODS

69

Chemicals. Guanidinium thiocyanate and ethanol were purchased for use in the

70

NucleoSpin miRNA plasma RNA extraction kit (Macherey-Nagel Inc., Bethlehem, PA).

71

TRIzol was purchased from Life Technologies (Grand Island, NY).

72

Milk and dairy products. Raw, whole, 2%, and skim cow’s (Bos taurus) milk was

73

obtained from The Pennsylvania State University Creamery (University Park, PA) from

74

separate collections in three consecutive weeks in May 2014. All milk was procured

75

from the Penn State Animal Science Department’s Holsteins breed herd. Milk was

76

pasteurized, homogenized, and bottled in the creamery facility within one day of receipt

77

into bulk tanks. On our initial collection dates, milk of all fat levels were stored at 4ºC

78

for up to 15 days, and aliquots were taken and frozen at -80ºC every other day. In a

79

separate experiment bovine cells were removed from raw milk by centrifugation (500 g,

80

10 min, 4°C) to determine whether somatic cells are a meaningful confounder when

81

analyzing the concentrations of miRNAs in milk from healthy cows. Samples were

82

frozen at -80°C and shipped on dry ice to Lincoln, NE, for miRNA analysis. Samples

83

from all fat levels of milk on day 15 were heated in the microwave for 15 seconds and

84

analyzed after cooling off to room temperature. Dairy products other than milk were
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purchased from grocery stores in Lincoln, NE. All samples were produced and analyzed

86

as biological repeats in triplicate.

87

MiRNA analysis. Milk samples were spiked with a synthetic internal standard (twenty-

88

five attomoles) prior to extraction of miRNAs using miSPIKE Synthetic RNA (IDT

89

Technologies).4 Dairy products (100 mg) other than milk were extracted using TRIzol

90

prior to addition of the synthetic internal standard. MiR-29b and miR-200c were

91

quantified using quantitative real-time PCR as described previously.4

92

Statistics. Analysis by Bartlett’s Test Homogeneity suggested that variances were

93

homogeneous.29 The paired t-test was used for pairwise comparisons. One-way analysis

94

of variance (ANOVA) and Fisher’s protected least significant differences were used

95

when comparing more than two groups. Repeated measures ANOVA was used for

96

assessing the effects of storage time on miRNA concentration. StatView 5.0.1 (SAS

97

Institute; Cary, NC) was used for conducting statistical analyses. Means ± SD are

98

reported. Differences were considered statistically significant if P≤ 0.05.

99
100
101

RESULTS
Pasteurization and homogenization of raw milk resulted in a 63±28% decrease of

102

miR-200c in whole milk; effects were similar for 2% fat milk and skim milk (Fig. 1A).

103

The effect was less pronounced for miR-29b for which a significant decrease (67±18%)

104

was observed only in skim milk (Fig. 1B). Cold storage of milk did not affect the

105

concentration of mir-29b and miR-200c in whole milk, 2% milk and skim milk up to 15

106

days; 2% fat milk is shown as a representative example in Fig. 2. Somatic cells are not

107

meaningful confounds regarding the analysis of miRNAs in milk from healthy cows.

70
108

When somatic cells were removed from raw milk by centrifugation and analyzed for

109

miRNA content, the cellular miRNAs were found to contribute less than 2% of the total

110

miRNAs present in raw milk before centrifugation: 1.1±0.9% for miR-29b and

111

0.14±0.08% for miR-200c.

112

Processing in the household has the potential to cause a considerable loss of some

113

miRNAs in milk. For example, the concentration of miR-29b decreased by 40±28% when

114

processed milk was heated in the microwave and cooled to room temperature compared

115

to milk before heating (Fig. 3). In contrast, when milk was heated in the microwave the

116

concentration of miR-200c was not statistically different compared with unheated

117

controls. The concentrations of miRNAs varied considerably among the dairy products

118

tested (Table 1), but were generally lower than the concentrations in pasteurized whole

119

milk (compare Fig. 1). Fresco Queso Dip was a notable exception and contained higher

120

concentrations of miRNAs than those observed in milk.

121
122

DISCUSSION

123

In a recent paper we reported the importance of milk miRNAs for gene regulation in

124

humans.4 That report has major implications for the roles of milk and possibly other dairy

125

products in human health. Cow’s milk contains meaningful quantities of 245 miRNAs,20,

126

30

127

(unpublished observations). In addition to the roles of miR-29b and miR-200c in bone

128

health and cancer prevention,16-17, 24-25 respectively, miRNAs have been implicated in

129

various aspects of human health and disease including hypertension, insulin resistance

and 71.4% of these miRNAs are predicted to target about 11,000 human transcripts

71
130

and diabetes, hyperlipidemia and atherosclerosis, reproduction, immune function and

131

Crohn’s disease.18, 20-21, 31-33

132

We propose that milk has a meaningful effect on human health, mediated by

133

miRNA-dependent gene regulation. The potential importance of dietary milk miRNA

134

intake is supported by data suggesting that 1) Americans consume large quantities of

135

milk and dairy products,28 2) a large proportion of milk miRNAs is encapsulated in

136

extracellular vesicles, thereby providing protection against degradation 5-6 and a pathway

137

for cellular uptake by endocytosis,34-35, and 3) milk miRNAs are resistant against

138

degradation during storage (this study).

139

Our previous studies of milk miRNAs in humans and mice were conducted using 1%

140

fat milk from the grocery store.4 Based on this study, the content of miRNAs is about two

141

times higher in unprocessed milk compared with pasteurized, store-bought milk. Note

142

that we have no intent recommending the consumption of raw cow’s milk by humans,

143

because of food safety concerns associated with raw milk. We observed that a loss of

144

milk miRNAs occurred only during pasteurization, homogenization, and processing to

145

dairy products. This observation is consistent with previous studies of milk miRNAs. For

146

example, endogenous miRNAs were not degraded when milk was exposed to harsh

147

treatments such as low pH or treatment with RNase.[Kosaka, 2010 #8963; Izumi, 2012

148

#8911] It is reasonable to propose that encapsulation of miRNAs in extracellular vesicles

149

[Zhou, 2012, #8913] prevents miRNA degradation, based on the following lines of

150

evidence. 1) When synthetic miRNAs are added to milk and subjected to low pH or

151

RNase treatment, the miRNAs are rapidly degraded. [Kosaka, 2010 #8963; Izumi, 2012

152

#8911] 2) When exosome membranes in milk were disrupted by sonication for preparing

72
153

miRNA-depleted mouse diets in previous studies, miR-29b was rapidly degraded to

154

concentrations below detection limit.[Baier, 2014 #10339] Presumably, degradation was

155

due to milk RNases gaining access to miRNAs released from exosomes. 3) When milk

156

was fermented to produce yoghurt, miRNA concentrations decreased to levels much

157

lower than in milk (this study). We speculate that the decrease was due to the lysis of

158

exosomes during fermentation and the large amounts of RNases produced by microbes.

159

4) When milk was homogenized, miRNA concentrations decreased by on average 50%

160

(this study). We speculate that the decrease was caused by a disruption of exosome

161

membranes by shear forces applied during homogenization. Collectively, our studies

162

suggest that milk, and perhaps dairy products, have the potential to contribute to the

163

miRNA body pool in humans.

164

Some uncertainties remain to be addressed in future studies. For example, this study

165

was modeled based on miR-29b and miR-200c, however, there is a possibility that

166

distinct miRNAs may be differentially metabolized.8, 36 Another layer of uncertainty is

167

the possible effects of feeding regimens, season, and breed on the miRNA content in

168

milk. Moreover, while this study suggests that somatic cells in milk from healthy cows do

169

not contribute meaningful amounts to the total miRNA content in milk, it is possible that

170

the increased somatic cell count in milk from cows suffering from mastitis37 may cause

171

an artificial increase in milk miRNA concentrations. Our previous studies suggest that

172

plasma miRNA concentrations decrease by 61% in mice fed a milk miRNA-depleted diet

173

for four weeks. This observation is consistent with milk miRNAs contributing

174

meaningful quantities to the miRNA body pool, but does not necessarily establish the

175

essentiality of dietary miRNA intake. Clearly, this is an uncertainty that will need to be

73
176

addressed in future studies. Finally, it is conceivable that miRNAs from foods other than

177

milk also contribute toward the total body pool of miRNAs.

178
179

ABBREVIATIONS USED

180

miR, microRNA; miRNA, microRNA

181
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Table 1. Concentration of miRNAs-29b and -200c in dairy products
MiRNA
_______________
Product

miR-29b

______________
miR-

200c
fmol/kg
Best Choice Yogurt

0.9±0.10

37.6±2.8

Fresco Queso Dip

36.1±5.5

1029.8±478.6

Greek Yogurt

14.2±3.9

462.3±126.9

Half and Half

3.0±0.17

513.3±159.2

Heavy Whip Cream

2.6±1.3

342.0±132.9

Parmesan Cheese

4.9±1.9

232.0±64.5

Upstate Farm Yogurt

2.4±1.0

216.9±93.8

Data are means±SD, n=3.
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Abstract
Sulforaphane is a naturally occurring isothiocyanate in cruciferous vegetables.
Sulforaphane inhibits histone deacetylases, leading to the transcriptional activation of
genes including tumor suppressor genes. The compound has attracted considerable
attention in the chemoprevention of prostate cancer. Here we tested the hypothesis that
sulforaphane is not specific for tumor suppressor genes but also activates loci such as
long terminal repeats (LTRs), which might impair genome stability. Studies were
conducted using chemically pure sulforaphane in primary human IMR-90 fibroblasts and
in broccoli sprout feeding studies in healthy adults. Sulforaphane and sprouts caused an
increase in LTR transcriptional activity in cell cultures and adults, respectively. For
example, the area under the curve for LTR mRNA increased by more than 10 times in
adults consuming broccoli sprouts compared with controls. The effect of sulforaphane
was dose dependent in the human feeding studies. This increase in transcript levels was
associated with an increase in histone H3 K9 acetylation marks in LTR 15 in peripheral
blood mononuclear cells from subjects consuming sprouts. Collectively, this study
suggests that sulforaphane has off-target effects that warrant further investigation when
recommending high levels of sulforaphane intake, despite its promising activities in
chemoprevention.
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1. Introduction
Cruciferous vegetables such as broccoli and cauliflower contain a large number of
glucosinolates including glucoerucin, glucoiberin, and glucoraphanin (1). When unheated
vegetables are processed by chopping or chewing, the enzyme myrosinase is released
from myrosin grains in myrosin cells and glucosinolates are released from adjacent S
cells (2-4). Myrosinase catalyzes the hydrolytic removal of the glucose moiety in
glucoraphanin, followed by non-enzymatic release of a hydrogen sulfate moiety and
spontaneous rearrangement of the unstable intermediate to form the aliphatic
isothiocyanate sulforaphane (SFN) (1). SFN has attracted considerable attention due to its
putative role in cancer prevention (5).
Various, not mutually exclusive, mechanisms have been proposed to explain the
chemopreventive activities of SFN. One theory is that SFN enhances drug-mediated
cytotoxicity against cancer cells including cancer stem cells (6-8). The significance of
these observations is not limited to the chemotherapy of cancer but extends to the
prevention of cancer through enhancing cellular sensitivity to cell death signals in tumor
initiation. SFN-dependent inhibition of anti-apoptotic NF-κB signaling pathways appear
to play a major role in the elimination of abnormal cells (9, 10). A second theory is that
SFN-dependent inhibition of histone deacetylases (HDACs) causes an increase in the
expression of tumor suppressor genes such as p21 and Bax, leading to cell cycle arrest
and apoptosis (11, 12). Evidence suggests that SFN inhibits class I and class II HDACs
(13). The locus (gene) specificity of SFN is uncertain, despite a general consensus that
chemoprevention needs to pursue gene-specific gene expression through the modulation
of epigenetic marks in distinct genomic loci (14). Gene-specific epigenetic editing can,
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theoretically, be achieved by fusing enzymes or inhibitors to gene-specific DNA binding
domains.
In this paper we tested the hypothesis that the inhibition of HDACs by SFN does
not only de-repress tumor suppressor genes, but also has undesirable off-target effects,
meditated be de-repression of genes other than tumor suppressor genes. Studies were
conducted in both cell cultures and healthy adults to take advantage of the small interindividual variation in cell cultures and to capture effects of biotransformation in human
studies. As model loci for detecting off-target effects we used long-terminal repeats
(LTRs), based on the following rationale.
LTRs make up about 8% of the human genome and at least 51 LTRs are
transcriptionally competent (15). Repetitive elements such as LTRs pose a burden to
genome stability, as their mobilization facilitates recombination between nonhomologous loci, leading to chromosomal deletions and translocations (16, 17).
Mobilization of LTR transposons is associated with 10% of all spontaneous mutations in
mice (18). The transcriptional activity of LTRs is controlled by histone acetylation and
other epigenetic marks; inhibition of HDACs leads to an increase in LTR transcription
(19). De-repression of LTRs may impair genome stability through insertional
mutagenesis, recombination events that cause translocations and other rearrangements,
de-regulation of genes in the host genome mediated by LTR promoter activity, and
antisense effects if transcription extends into exon sequence downstream of the
transposon (20).

2. Methods and Materials
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2.1. Cell cultures

Primary human IMR-90 fibroblasts were obtained from American Type Culture
Collection (Manassas, VA). We chose primary cells over cell lines to avoid possible
artifacts caused by the process of immortalization in cell lines. Fibroblasts (from passages
32-36) were cultured in Minimum Essential Medium (MEM) supplemented with 10%
fetal bovine serum, 0.1% sodium pyruvate, 100,000 U/L penicillin,100 mg/L
streptomycin, and 0.1% non-essential amino acids (final concentrations). R,S-SFN was
obtained from LKT Laboratories (St. Paul, MN) and was dissolved in DMSO to prepare a
stock solution containing 40 mmol/l SFN. Aliquots were frozen at -20°C until use. SFN
concentrations in cell culture media were adjusted to a final concentration of 2.0 µmol/l;
controls were treated with solvent. Samples were collected at timed intervals.

2.2. Human feeding study

Eight apparently healthy adults (4 male, 4 female) participated in a broccoli
sprout feeding study. Exclusion criteria included pregnancy, smoking, self-reported
health problems, and use of SFN supplements. Participants in this study included 6
Caucasians (2 Hispanics) and 2 Asians ages 19-30 years. Subjects were instructed not to
consume cruciferous vegetables in the 48 hours leading up to the study and during the
eight-hour period in which blood samples were collected. Each subject consumed three
doses (34 g, 68 g, 102 g) of BroccoSprouts® broccoli sprouts from a local supermarket
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(HyVee, Lincoln, NE). Sprouts were consumed with a bagel and cream cheese (11). Each
treatment was separated by a two week washout period and the order of doses was
randomized. Thirty milliliters of blood were collected before sprout consumption
(baseline, time 0 h) and at timed intervals (2, 4, and 8 h) after consumption. Peripheral
blood mononuclear cells (PBMC) and plasma were purified using Histopaque and
gradient centrifugation as described previously (21); aliquots were frozen at -80°C until
analysis.

2.3. Quantitation of SFN
SFN was extracted and quantitated by HPLC as previously described (22).
Briefly, 1 g of BroccoSprouts® was combined with 20 ml of water acidified with 0.1 M
hydrochloric acid and homogenized for 10-15 seconds with a Tissue-Tearor model
985370 hand-held homogenizer (Biospec Products, Inc., Bartlesville, OK). Extracts were
transferred to a 45°C water bath for 2 hours and then cooled to room temperature. The
solution was extracted twice with 20 ml dichloromethane and the solvent phases were
collected and combined. The solvent was dried through sodium sulfate and then loaded
onto a Supelclean™ LC-Florisil® SPE column (Supelco). The column was washed with
3 ml ethyl acetate and SFN was collected with 3 ml methanol. Samples were passed
through a 0.2 μm filter and stored at -20°C until analysis. Determination of SFN
concentration was performed by injection on a Waters (Milford, MA) 600S HPLC system
equipped with a VyDac C18 (Grace, Deerfield, IL) column and a Waters 2996
Photodiode Array detector. Separation was achieved with an isocratic flow rate of 1.0
ml/min using water and acetonitrile (30:70 v/v). A sample volume of 20 μl was injected.
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2.4. Quantitative Real-Time PCR (qRT-PCR)

The abundance of p21 mRNA and LTR mRNA (transcript R/U5) was quantified
by qRT-PCR as previously described using the cycle threshold method; glyceraldehyde3-phosphate dehydrogenase (GAPDH) was used to normalize for PCR efficiency (23,
24). PCR primer sequences for p21 were 5’-AGGCGGTTATGAAATTCACC-3’
(forward) and 5’-CCCTTCAAAGTGCCATCTG-3’ (reverse). LTR primer sequences
were the same as previously reported (25). Note that the values for LTR mRNA represent
the grand total of all transcriptionally active LTRs due to near-identical sequences in
these repeats (25). Areas under the curves (AUCs) for LTR mRNA were calculated using
the linear trapezoidal rule (26).

2.5. Chromatin Immunoprecipitation (ChIP) assays

ChIP assays were performed as previously described (23). Antibody against K9acetylated histone H3 (H3K9ac; ab10812) was purchased from Abcam (Cambridge,
MA). Data were normalized for nucleosomal occupancy using an antibody to the Cterminus in histone H3. The enrichment of H3K9ac marks in LTR15 {nomenclature as
per (15)} were quantified by qRT-PCR, using GAPDH as a control. PCR primer
sequences were the same as in our previous studies (25). In case of ChIP assays, as
opposed to mRNA quantification, individual LTRs can be distinguished by having one
PCR primer anneal with sequences in the host genome adjacent to the LTR of interest.
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2.6. Statistics

Homogeneity of variances was tested using Bartlett’s Test. If variances were
heterogeneous, data was log transformed before analysis. Data from IMR90 cell cultures
were analyzed by using the Wilcoxon Signed-Rank Test. Data from PBMC experiments
were analyzed using one-way analysis of variance (ANOVA) and Fisher’s LSD for
posthoc comparisons (27) for gene expression data and Wilcoxon Signed-Rank Test for
ChIP data. Differences were considered statistically significant if p<0.05. StatView 5.0.1
was used for conducting statistical analyses (SAS Institute; Cary, NC).

3. Results

3.1. LTR transcript levels increase after SFN treatment in IMR-90 fibroblast cultures

SFN de-repressed LTRs in IMR-90 fibroblasts (Fig. 1). A significant increase in
LTR mRNA was detectable at t = 4 h, and peak values were achieved at t = 6 h compared
with vehicle controls. LTR expression levels returned to baseline levels after 16 h of SFN
treatment. The expression of the p21 tumor suppressor also increased in response to SFN
treatment (Fig. 2), consistent with previous reports in BPH-1, LnCaP, and PC-3 prostate
epithelial cells (28), but this increase in p21 mRNA was not statistically significant.
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3.2. Human consumption of broccoli sprouts increases LTR expression and histone
acetylation

The expression of LTRs increased dose-dependently in response to consumption
of broccoli sprouts, as judged by the AUCs for LTR mRNA in PBMC (Fig. 3). The
AUCs for LTR transcripts in subjects consuming 34 g, 68 g, and 102 g sprouts were 1.29
± 2.38, 5.54 ± 5.26, and 13.06 ± 23.68 arbitrary units, respectively, compared with
baseline. The increase was significantly greater for the 68 g and 102 g doses compared
with the 34 g dose (p<0.05, N=8). The AUCs for p21 mRNA in subjects consuming 34 g,
68 g, and 102 g sprouts were 0.80 ± 1.43, 0.73 ± 0.90, 2.46 ± 3.00 arbitrary units,
respectively, compared with baseline; however the differences were not statistically
significant (p>0.05, N=8). Note that the level of SFN in Broccosprouts® was 18 mg/g
fresh weight.
The de-repression of LTRs was associated with an increased abundance of
H3K9ac marks in LTR15 at t = 4 h compared with t = 0 h (Fig. 4A). The magnitude of
the effect depended on the amount of broccoli sprouts that was consumed; meaningful
increases in H3K9ac enrichment at t = 4 h were observed when sprout doses exceeded 34
g (Fig. 4B).

4. Discussion

To the best of our knowledge, this is the first report suggesting possible off target
effects of SFN in the de-repression of LTRs in both primary cells and human feeding
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studies. The increase in LTR mRNA abundance was not only statistically significant but
also appears to be of biological importance, considering that the AUC for LTR mRNA
increased by more than 10 times for the highest dose of broccoli sprouts. The doses tested
in cell cultures and feeding studies are nutritionally relevant (29). Our observations were
corroborated by an increase in the abundance of H3K9ac marks in LTRs, consistent with
their de-repression. Note that SFN also increased the expression of the tumor suppressor
gene p21, albeit to a smaller extent than previously reported (30). The comparably small
increase in p21 expression in response to SFN might be due to us using nutritionally
meaningful levels, whereas other studies typically concentrations of at least 15 µmol/l
SFN (9, 31-33).
Our observations are important for human health, considering the roles of LTRs
in impairing genome stability (see Introduction) and the widespread availability of SFNcontaining foods and supplements. The sprouts used in this study, Broccosprouts®, are
widely available in the United States; the lowest dose that was tested, 34 g, is about one
serving according to product labeling. One serving of broccoli sprouts may contain levels
of SFN sufficient to de-repress LTRs. SFN-containing supplements are also available to
consumers over the counter. To the best of our knowledge, there are no data available for
the consumption of SFN supplements in the United States, but supplement use in general
is fairly common. For example, approximately 50% of all Americans and 64-81%, of
cancer survivors take nutritional supplements (34). Of the many SFN supplements on the
market, wide ranges of doses are available. One product, BroccoMax® is a supplement
labeled as having 30 mg sulforaphane glucosinolate per serving, providing a dose of SFN
similar to the dose tested in this study. One could assume with a reasonable level of
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confidence that consuming such doses of SFN on a regular basis could elicit effects
exceeding those seen in this study where single doses were administered. Note that we do
not dispute the potential benefits of SFN in the chemoprevention of cancer (6-8, 11, 12).
However, we propose that SFN needs to be considered in the context of gene-specific
editing (14).
There are some uncertainties that need to be addressed in future studies. First, the
effects of SFN on the de-repression of LTRs (and p21) are transient, and it remains to be
determined whether a de-repression that last a few hours is sufficient to elicit biologically
meaningful effects. Second, while the de-repression of LTRs was quantitatively
important, it remains to be seen whether the observed increase in LTR expression is
sufficient to impair genome stability.
Collectively, this study suggests that sulforaphane has off-target effects that
warrant further investigation when recommending high levels of sulforaphane intake,
despite its promising activities in chemoprevention.
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Fig. 1. SFN increases LTR transcription in IMR-90 fibroblast cultures. Fibroblasts were
treated with 2.0 µmol/l SFN (squares) or solvent (triangles). *Significantly different
compared with vehicle control at the same collection time (p<0.05 by Wilcoxon SignedRank test, N=4-7).
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Figure 2
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Fig. 2. SFN had no significant effect on p21 transcription in IMR-90 fibroblast cultures.
Fibroblasts were treated with 2.0 µmol/l SFN (squares) or solvent (triangles).
*Significantly different compared with vehicle control at the same collection time
(p<0.05 by Wilcoxon Signed-Rank test, N=4-7).
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Figure 3
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Fig. 3. AUC for LTR (black bars) and p21 (gray bars) expression increases in a dosedependent manner following three broccoli sprout doses in healthy adults. Statistical
significance determined by ANOVA with Fisher’s LSD used for posthoc comparisons.
a,b
Columns not sharing the same letters are significantly different for the same treatment
group (SFN vs. control; p<0.05, N=8).
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Figure 4
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Fig 4. (A) Broccoli sprout consumption increases enrichment of H3K9ac mark in LTR15
in PBMCs from human subjects consuming 102 g broccoli sprouts. *Significantly
different than controls as per Wilcoxon Signed-Rank test (p<0.05, N=8). (B) Doseresponse curve for the H3K9ac mark in LTR15 in PBMCs from a representative subject.
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Figure 4B
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OUTLOOK
The concept of dietary microRNAs is still relatively new in the nutrition field and while
the potential importance of bioavailable nucleic acids cannot be overlooked, much more
work needs to be done before we fully understand the function and impact of these
molecules. Initial reports indicating the bioavailability of plant-based microRNAs have
largely been refuted, but the results presented here in favor of milk and egg-derived
microRNA availability show there is great potential for dietary microRNA-based gene
regulation that may result in phenotypic changes on the organism level. To investigate
dietary microRNA further, certain projects are underway and planned that will greatly
increase our knowledge in this area.

1. Sonicated milk/eggs feeding study

Sonication of milk was used in making the ExoMinus diet in the mouse feeding study
presented in Chapter I. While not initially planned as part of the human feeding study, we
now have started another study with feeding subjects 1.0 L of sonicated milk. Since most
miRNA do not remain in the milk following sonication, the expected response in regard
to plasma miRNA concentrations and resulting PBMC gene expression changes should
not occur, or at least to a much lesser extent. This study will provide important evidence
showing the changes in miRNA abundance and gene expression in tissues are truly due to
exogenously supplied miRNA. Similar studies will also be performed for the egg feeding
study presented in Chapter II.
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2. Mouse phenotyping study

In Chapter I, a short term mouse feeding study was presented where mice were fed diets
named ExoPlus, meaning it was sufficient in exosomal/microRNA content or ExoMinus,
where the microRNA were depleted by sonication. While this study provided interesting
results showing mice are not able to make up for decreased dietary microRNA by
upregulating endogenous genes, it was likely too short of a study and too few mice to
determine phenotypic effects of long-term consumption of milk microRNAs. Currently, a
larger study is underway where mice are being fed the same two diets with tissue
collections occurring at different time points throughout life. In addition, breeding
success and the viability and success of offspring will be measured. Also, unlike the pilot
study, both male and female mice will be included to examine any potential gender
specific effects.

3. Comparison of milk and dairy consumers versus non-consumers

One of the outcomes of the pilot study in mice from Chapter I was the observation that
some liver metabolites were present in different levels when comparing mice on the
ExoPlus versus ExoMinus diets. In particular, metabolites in the purine metabolism
pathway, including xanthine and uric acid, were more abundant in the livers of mice on
the ExoMinus diet. This observation has also been made in human plasma samples when
comparing two consumers of milk to one non-consumer. While in the early stages, the
encouraging results from the mouse study and limited analysis of human samples has let
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us to begin recruitment of more individuals for the human sample analysis. In addition to
plasma samples, 24 hour urine collections will be performed to allow for analysis of urine
metabolites.

4. Fortification of infant formulas with milk-derived exosomes

One of the observations made in our lab is breast milk has significantly greater amounts
of miRNA than infant formulas. This is probably due, in part, to the large effect
processing has on the abundance of miRNA in milk (see Chapter III). Additionally, plant
based formulas contain none of the same miRNA as naturally found in breast milk. If
possible, the addition of milk exosomes into formula powder preparations could improve
the overall nutritional profile of infant formulas and make up for the differences in the
health outcomes of infants on formula-based diets compared to breast-fed counterparts.
This study will be performed by feeding human adults two different 1.0 L drinks. One
will be a soy infant formula mixed according to label recommendations. The other will be
the same formula with supplemented cow’s milk exosomes to obtain a similar miRNA
profile as seen in cow’s milk. Theoretically there will not be a change to plasma miRNA
following consumption of soy formula alone, but the supplemented formula should result
in plasma miRNA increases similar to that of the study perform in Chapter II.
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5. Determination of bone health in infants based on feeding regimen

Infants fed breast milk have greater BMD for the first few months of life compared to
formula fed infants. We hypothesize the miRNA in breast milk may be partially
responsible for this difference (see the effects of miR-29b in Chapter I) and are in the
process of collecting samples from infants on different diets. In this study, mothers are
providing milk samples, both breast milk and formula milk, and collecting infant urine
once monthly until 6 months of age. The urine and milk miRNA content will be analyzed
as well as the presence of different markers of bone health in the urine. We expect that
the miRNA content of the infant’s diet impacts markers of bone formation and
breakdown. This study has enrolled a few infant/mother pairs and active recruitment is
currently underway.

6. Use of milk-derived exosomes as drug delivery vehicles

Cow’s milk exosomes are widely available and cheap to obtain when compared to
exosomes produced in cell culture chambers. Additionally, since many cell cultures are
from cancer cell lines, there are many concerns about the exosomes derived from those
cells having the potential to transfer the cancer phenotype to recipient cells. Since we
have observed encouraging results from the studies present in this dissertation and from
the work of other students, pilot studies were performed regarding drug loading of
exosomes. By using electroporation we have been able to transfect exosomes with drug
and plasmid DNA and subsequently measure uptake by recipient cells treated with the
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transfected exosomes. This project is in the early stages, but once conditions are
optimized it may open the door for use of bovine milk exosomes as an inexpensive way
to package drugs that cannot currently be consumed orally because of degradation in the
gastrointestinal tract.

